Observational study / 2019
Internal glycidol doses in children corresponded to an estimated mean intake of 1.4 μg/kg/day and an estimated lifetime cancer risk of 200/10⁵.
Internal doses of the foodborne genotoxic carcinogen glycidol were determined in 50 children and 12 adults by measuring the hemoglobin adduct N-(2,3-dihydroxypropyl)valine. Hemoglobin adduct levels demonstrated a fivefold variation among the children, with an estimated mean intake of 1.4 μg/kg/day, which was about two times higher than the European Food Safety Authority's estimate for children. Non-smoking adults showed exposure levels similar to children, while smoking adults had higher levels. Using a multiplicative risk model, the estimated lifetime cancer risk calculated from the children's in vivo doses was 200/10⁵, exceeding what is considered acceptable.
Shows an association, not proof of cause and effect.
- Study type
- Cohort / biomonitoring study
- Who was studied
- 50 children and a reference group of 12 adults (non-smokers and smokers)
- What was measured
- Hemoglobin adduct levels, estimated in vivo doses/intakes of glycidol, and calculated lifetime cancer risk
THE PAPER
Internal Doses of Glycidol in Children and Estimation of Associated Cancer Risk.
Aasa J, Vryonidis E, Abramsson-Zetterberg L, Törnqvist M. Toxics, 2019.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.